✦ LIBER ✦

How the Human Genome Can Predict Response to Hepatitis C Therapy

✍ Scribed by Alexander J. Thompson; Jacques Fellay; John G. McHutchison

Book ID: 107540516
Publisher: Current Science Inc.
Year: 2010
Tongue: English
Weight: 250 KB
Volume: 9
Category: Article
ISSN: 1540-3416
DOI: 10.1007/s11901-010-0029-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The initial laparoscopic appearance can

The initial laparoscopic appearance can predict response to combination therapy in hepatitis C

✍ Jasmohan S Bajaj; Enrique Molina; K.R Reddy; Eugene R Schiff; Lennox J Jeffers 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 25 KB

Viral kinetics can predict early respons

Viral kinetics can predict early response to alpha-interferon in chronic hepatitis C

✍ K. M. Walsh; T. Good; S. Cameron; D. Thorburn; E. A. B. McCruden; P. R. Mills; A 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB

Earlier loss of hepatitis C virus RNA in

Earlier loss of hepatitis C virus RNA in interferon therapy can predict a long-term response in chronic hepatitis C

✍ SHINICHI KAKUMU; TOSHIYUKI AIYAMA; AKIHIKO OKUMURA; KAZUO IWATA; TETSUYA ISHIKAW 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB

Can radionuclide imaging predict future

Can radionuclide imaging predict future response to stem cell therapy?

✍ Joseph C. Wu 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 43 KB

Predictive factors in the response to in

Predictive factors in the response to interferon therapy in chronic hepatitis C

✍ Kentaro Yoshioka; Yasuyuki Higashi; Masaki Yamada; Toshiyuki Aiyama; Masahiro Ta 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 548 KB

Factors predictive of a beneficial respo

Factors predictive of a beneficial response to therapy of hepatitis C

✍ G L Davis; J Y Lau 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

disease. 2 Many of these studies identified pretreatment pa-Alpha interferon is the only drug that has been shown to tient characteristics that are associated with a greater or lesser be effective in the treatment of chronic hepatitis C, but only likelihood of response to interferon (Table 1). The m